Acumen Pharmaceuticals Stock Equity Positions Weight

ABOS Stock

USD 1.45 0.01 0.68%

Acumen Pharmaceuticals fundamentals help investors to digest information that contributes to Acumen Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Acumen Stock. The fundamental analysis module provides a way to measure Acumen Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Acumen Pharmaceuticals stock.

Other Current Liab Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Acumen Pharmaceuticals Company Equity Positions Weight Analysis

Acumen Pharmaceuticals' Percentage of fund asset invested in equity instruments. About 80% of global funds and ETFs carry equity instruments on their balance sheet.

Stock Percentage

% of Equities

in the fund

More About Equity Positions Weight | All Equity Analysis

Acumen Equity Positions Weight Driver Correlations

Understanding the fundamental principles of building solid financial models for Acumen Pharmaceuticals is extremely important. It helps to project a fair market value of Acumen Stock properly, considering its historical fundamentals such as Equity Positions Weight. Since Acumen Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Acumen Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Acumen Pharmaceuticals' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Capital Surpluse	Short Term Debt	Common Stock	Property Plant Equipment	Long Term Debt
Total Assets		0.99	0.96	-0.55	-0.97	0.91	0.79	0.2	1.0	0.94	0.94	0.78	0.88	0.8	0.83	-0.7
Total Stockholder Equity	0.99		0.98	-0.6	-0.98	0.92	0.73	0.1	1.0	0.95	0.95	0.75	0.84	0.77	0.83	-0.67
Net Tangible Assets	0.96	0.98		-0.72	-0.96	0.94	0.6	0.0	0.97	0.95	0.95	0.66	0.73	0.66	0.79	-0.58
Net Debt	-0.55	-0.6	-0.72		0.61	-0.75	0.0	0.16	-0.56	-0.66	-0.67	-0.13	-0.1	-0.08	-0.45	0.06
Retained Earnings	-0.97	-0.98	-0.96	0.61		-0.96	-0.72	-0.17	-0.98	-0.96	-0.96	-0.69	-0.83	-0.78	-0.91	0.57
Accounts Payable	0.91	0.92	0.94	-0.75	-0.96		0.58	0.17	0.91	0.97	0.97	0.64	0.68	0.69	0.91	-0.43
Net Receivables	0.79	0.73	0.6	0.0	-0.72	0.58		0.59	0.76	0.65	0.64	0.82	0.97	0.89	0.69	-0.78
Total Liab	0.2	0.1	0.0	0.16	-0.17	0.17	0.59		0.13	0.21	0.2	0.26	0.38	0.46	0.25	-0.12
Net Invested Capital	1.0	1.0	0.97	-0.56	-0.98	0.91	0.76	0.13		0.94	0.94	0.76	0.87	0.79	0.83	-0.69
Total Current Assets	0.94	0.95	0.95	-0.66	-0.96	0.97	0.65	0.21	0.94		1.0	0.68	0.75	0.79	0.87	-0.44
Net Working Capital	0.94	0.95	0.95	-0.67	-0.96	0.97	0.64	0.2	0.94	1.0		0.67	0.74	0.78	0.87	-0.44
Capital Surpluse	0.78	0.75	0.66	-0.13	-0.69	0.64	0.82	0.26	0.76	0.68	0.67		0.86	0.84	0.72	-0.83
Short Term Debt	0.88	0.84	0.73	-0.1	-0.83	0.68	0.97	0.38	0.87	0.75	0.74	0.86		0.92	0.78	-0.8
Common Stock	0.8	0.77	0.66	-0.08	-0.78	0.69	0.89	0.46	0.79	0.79	0.78	0.84	0.92		0.82	-0.57
Property Plant Equipment	0.83	0.83	0.79	-0.45	-0.91	0.91	0.69	0.25	0.83	0.87	0.87	0.72	0.78	0.82		-0.46
Long Term Debt	-0.7	-0.67	-0.58	0.06	0.57	-0.43	-0.78	-0.12	-0.69	-0.44	-0.44	-0.83	-0.8	-0.57	-0.46

Click cells to compare fundamentals

Funds with most asset allocated to stocks can be subclassified into many different categories such as market capitalization or investment style.

Competition

Predict Acumen Pharmaceuticals

According to the company disclosure, Acumen Pharmaceuticals has an Equity Positions Weight of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Did you try this?

Run Odds Of Bankruptcy Now

Odds Of Bankruptcy

Get analysis of equity chance of financial distress in the next 2 years

All Next

Launch Module

Acumen Fundamentals

	Return On Equity	-0.33
	Return On Asset	-0.21
	Current Valuation	(84.76 M)
	Shares Outstanding	60.08 M
	Shares Owned By Insiders	11.23 %
	Shares Owned By Institutions	76.53 %
	Number Of Shares Shorted	1.84 M
	Price To Book	0.40 X
	Price To Sales	538.78 X
	Gross Profit	(43.56 M)
	EBITDA	(51.61 M)
	Net Income	(52.37 M)
	Cash And Equivalents	189.91 M
	Cash Per Share	4.69 X
	Total Debt	28.49 M
	Current Ratio	37.21 X
	Book Value Per Share	3.62 X
	Cash Flow From Operations	(43.06 M)
	Short Ratio	5.78 X
	Earnings Per Share	(1.38) X
	Price To Earnings To Growth	(0.23) X
	Target Price	10.8
	Number Of Employees	51
	Beta	-0.006
	Market Capitalization	87.12 M
	Total Asset	310.12 M
	Retained Earnings	(222.8 M)
	Working Capital	233.64 M
	Net Asset	310.12 M

About Acumen Pharmaceuticals Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Acumen Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Acumen Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Acumen Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Acumen Stock Analysis

When running Acumen Pharmaceuticals' price analysis, check to measure Acumen Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acumen Pharmaceuticals is operating at the current time. Most of Acumen Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acumen Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acumen Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acumen Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC